Folgen

  • All About Allergies: The Evolution of Care & Evidence with Dr. Zach Rubin

    All About Allergies: The Evolution of Care & Evidence with Dr. Zach Rubin
    Feb 11 2026
    Double-board-certified pediatrician and allergist/immunologist Zach Rubin joins Manesh Patel for an evidence-based discussion on allergy science. The conversation dives into the differences between allergies and sensitivities, recent shifts in food allergy prevention, environmental and metal allergies, and FDA-approved treatments, including Xolair and needle-free EpiPens. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-11-all-about-allergies-evolution-care-evidence-dr-zach-rubin
    Mehr anzeigen Weniger anzeigen
    31 Min.
  • From Innovation to Implementation: AI in Action

    From Innovation to Implementation: AI in Action
    Jan 28 2026
    Guests Michael Pencina and Suresh Balu join the Beyond the Endpoint hosts to explore the impact of AI in healthcare. They discuss the role of AI-powered tools in research, clinical care, and operations, while examining evidence standards, transparency challenges, and the potential evolution of the physician-patient relationship. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-10-innovation-implementation-ai-action
    Mehr anzeigen Weniger anzeigen
    26 Min.
  • Beyond the Headlines Series: Looking back at 2025 headlines, Dementia & Vaccines, and Cannabis Research

    Beyond the Headlines Series: Looking back at 2025 headlines, Dementia & Vaccines, and Cannabis Research
    Jan 14 2026
    Kick off 2026 with hosts Manesh Patel and Emily O'Brien as they evaluate last year's most discussed health stories and wellness trends, cannabis reclassification, and a shingles vaccine-dementia study. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-9-beyond-headlines
    Mehr anzeigen Weniger anzeigen
    21 Min.
  • Behind the Voices: Get to Know Emily & Manesh

    Behind the Voices: Get to Know Emily & Manesh
    Dec 17 2025
    Hosts Manesh Patel and Emily O'Brien share their amusing and inspiring personal and professional trajectories, exploring how mentors shaped their paths in clinical research, why asking unconventional questions matters, and how success rarely follows a straight line. 🎙️ Listen now for the full conversation: https://dcri.org/blog/s2-ep-8-behind-voices-get-know-emily-manesh
    Mehr anzeigen Weniger anzeigen
    28 Min.
  • From Provider to Patient: A Dual Perspective on Colorectal Cancer

    From Provider to Patient: A Dual Perspective on Colorectal Cancer
    Dec 3 2025
    Hosts Emily O’Brien and Manesh Patel sit down with Dr. Ajay Kohli and Dr. Julius Wilder for a dual-perspective conversation on colorectal cancer, where they discuss personal experiences, the importance of early detection, screening disparities, and how equitable access to care saves lives. 🔗Access resources related to this episode: https://dcri.org/blog/s2-ep-7-provider-patient-dual-perspective-colorectal-cancer
    Mehr anzeigen Weniger anzeigen
    39 Min.
  • Beyond the Headlines: Recap of the 2025 AHA Scientific Sessions

    Beyond the Headlines: Recap of the 2025 AHA Scientific Sessions
    Nov 19 2025
    Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-6-beyond-headlines #AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
    Mehr anzeigen Weniger anzeigen
    21 Min.
  • Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

    Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next
    Nov 4 2025
    Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-5-connecting-dots-broader-applications-glp-1s-and-where-were-headed-next
    Mehr anzeigen Weniger anzeigen
    37 Min.
  • Obesity, GLP-1s, and the Evidence: What the Data Tells Us

    Obesity, GLP-1s, and the Evidence: What the Data Tells Us
    Oct 22 2025
    In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us
    Mehr anzeigen Weniger anzeigen
    31 Min.